Here's Why GenMark Diagnostics Is Rising Today
Shares of GenMark Diagnostics (NASDAQ: GNMK), a company focused on molecular tests, rose as much as 30% in early morning trading on Wednesday. A lot of the early gains have since been erased, but the stock was still up about 14% as of 12:05 p.m. EDT.
Today's rally is a response to the news that GenMark submitted its ePlex SARS-CoV-2 Test to the Food and Drug Administration (FDA) for an Emergency Use Authorization (EUA). Management also noted that Research Use Only (RUO) versions of its tests were sent out last week to some of its customers for validation.
Image source: Getty Images.
Source Fool.com
